SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Sean G. Smith, Bhanu prasanth Koppolu, Sruthi Ravindranathan, Samantha L. Kurtz, Lirong Yang, Matthew D. Katz, David A. Zaharoff, Intravesical chitosan/interleukin-12 immunotherapy induces tumor-specific systemic immunity against murine bladder cancer, Cancer Immunology, Immunotherapy, 2015,

    CrossRef

  2. 2
    Yme Weijers, Harm C. Arentsen, Tom J.H. Arends, J. Alfred Witjes, Management of Low-risk and Intermediate-risk Non–Muscle-invasive Bladder Carcinoma, Hematology/Oncology Clinics of North America, 2015, 29, 2, 219

    CrossRef

  3. 3
    Luis A. Kluth, Peter C. Black, Bernard H. Bochner, James Catto, Seth P. Lerner, Arnulf Stenzl, Richard Sylvester, Andrew J. Vickers, Evanguelos Xylinas, Shahrokh F. Shariat, Prognostic and Prediction Tools in Bladder Cancer: A Comprehensive Review of the Literature, European Urology, 2015,

    CrossRef

  4. 4
    Karim Chamie, Eric Ballon-Landa, Timothy J. Daskivich, Jeffrey C. Bassett, Julie Lai, Jan M. Hanley, Badrinath R. Konety, Mark S. Litwin, Christopher S. Saigal, Treatment and survival in patients with recurrent high-risk non–muscle-invasive bladder cancer, Urologic Oncology: Seminars and Original Investigations, 2015, 33, 1, 20.e9

    CrossRef

  5. 5
    T. Behrens, B. Pesch, T. Brüning, Tumormarkerforschung für die klinische Praxis, Der Onkologe, 2015, 21, 3, 250

    CrossRef

  6. 6
    Anthony T. Corcoran, Elizabeth Handorf, Daniel Canter, Jeffrey J. Tomaszewski, Justin E. Bekelman, Simon P. Kim, Robert G. Uzzo, Alexander Kutikov, Marc C. Smaldone, Variation in performance of candidate surgical quality measures for muscle-invasive bladder cancer by hospital type, BJU International, 2015, 115, 2
  7. 7
    Behfar Ehdaie, Coral L. Atoria, William T. Lowrance, Harry W. Herr, Bernard H. Bochner, S. Machele Donat, Guido Dalbagni, Elena B. Elkin, Adherence to surveillance guidelines after radical cystectomy: A population-based analysis, Urologic Oncology: Seminars and Original Investigations, 2014, 32, 6, 779

    CrossRef

  8. 8
    B. Pesch, T. Brüning, G. Johnen, S. Casjens, N. Bonberg, D. Taeger, A. Müller, D.G. Weber, T. Behrens, Biomarker research with prospective study designs for the early detection of cancer, Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics, 2014, 1844, 5, 874

    CrossRef

  9. 9
    B. Miñana, J.M. Cózar, J. Palou, M. Unda Urzaiz, R.A. Medina-Lopez, Jorge Subirá Ríos, F. de la Rosa-Kehrmann, V. Chantada-Abal, F. Lozano, Maria J. Ribal, E. Rodríguez Fernández, J. Castiñeiras Fernández, Tomás Concepción Masip, M.J. Requena-Tapia, J. Moreno-Sierra, M. Hevia, A. Gómez Rodríguez, C. Martínez-Ballesteros, M. Ramos, José H. Amón Sesmero, P. Pizá Reus, A. Bohorquez Barrientos, Carlos Rioja Sanz, J. Angel Gomez-Pascual, E. Hidalgo Zabala, J.L. Parra Escobar, O. Serrano, Bladder Cancer in Spain 2011: Population Based Study, The Journal of Urology, 2014, 191, 2, 323

    CrossRef

  10. 10
    Rianne J.M. Lammers, Joan Palou, Wim P.J. Witjes, Maria H.D. Janzing-Pastors, Christien T.M. Caris, J. Alfred Witjes, Comparison of expected treatment outcomes, obtained using risk models and international guidelines, with observed treatment outcomes in a Dutch cohort of patients with non-muscle-invasive bladder cancer treated with intravesical chemotherapy, BJU International, 2014, 114, 2
  11. 11
    Christopher P. Filson, Jeffrey S. Montgomery, Stephen M. Dailey, Heather S. Crossley, Heidi Lentz, Christopher T. Tallman, Chang He, Alon Z. Weizer, Complications associated with single-dose, perioperative mitomycin-C for patients undergoing bladder tumor resection, Urologic Oncology: Seminars and Original Investigations, 2014, 32, 1, 40.e1

    CrossRef

  12. 12
    Bernd J. Schmitz-Dräger, Tilman Todenhöfer, Bas van Rhijn, Beate Pesch, Mĺiss A. Hudson, Ashish Chandra, Molly A. Ingersoll, Wassim Kassouf, Joan Palou, John Taylor, Antonia Vlahou, Thomas Behrens, Rossana Critelli, H. Barton Grossman, Marta Sanchez-Carbayo, Ashish Kamat, Considerations on the use of urine markers in the management of patients with low-/intermediate-risk non–muscle invasive bladder cancer, Urologic Oncology: Seminars and Original Investigations, 2014, 32, 7, 1061

    CrossRef

  13. 13
    Marc A. Kowalkowski, Heather Honoré Goltz, Nancy J. Petersen, Gilad E. Amiel, Seth P. Lerner, David M. Latini, Educational Opportunities in Bladder Cancer: Increasing Cystoscopic Adherence and the Availability of Smoking-Cessation Programs, Journal of Cancer Education, 2014, 29, 4, 739

    CrossRef

  14. 14
    Alexander Karl, Oluwakayode Adejoro, Christopher Saigal, Badrinath Konety, General Adherence to Guideline Recommendations on Initial Diagnosis of Bladder Cancer in the United States and Influencing Factors, Clinical Genitourinary Cancer, 2014, 12, 4, 270

    CrossRef

  15. 15
    James E. Montie, Guideline application and the real world, Urologic Oncology: Seminars and Original Investigations, 2014, 32, 4, 377

    CrossRef

  16. 16
    Matthew J. Pagano, Gina Badalato, James M. McKiernan, Optimal Treatment of Non-Muscle Invasive Urothelial Carcinoma Including Perioperative Management Revisited, Current Urology Reports, 2014, 15, 11

    CrossRef

  17. 17
    Beate Pesch, Dirk Taeger, Georg Johnen, Katarzyna Gawrych, Nadine Bonberg, Christian Schwentner, Harald Wellhäußer, Matthias Kluckert, Gabriele Leng, Michael Nasterlack, Yair Lotan, Arnulf Stenzl, Thomas Brüning, Screening for bladder cancer with urinary tumor markers in chemical workers with exposure to aromatic amines, International Archives of Occupational and Environmental Health, 2014, 87, 7, 715

    CrossRef

  18. 18
    Marius Roaldsen, Erling Aarsaether, Tore Knutsen, Hiten RH Patel, Strategies to improve quality of life in bladder cancer patients, Expert Review of Pharmacoeconomics & Outcomes Research, 2014, 14, 4, 537

    CrossRef

  19. 19
    Matthew Mossanen, John L. Gore, The burden of bladder cancer care, Current Opinion in Urology, 2014, 24, 5, 487

    CrossRef

  20. 20
    Juan Palou-Redorta, Morgan Rouprêt, Jack R. Gallagher, Kylee Heap, Catherine Corbell, Brent Schwartz, The use of immediate postoperative instillations of intravesical chemotherapy after TURBT of NMIBC among European countries, World Journal of Urology, 2014, 32, 2, 525

    CrossRef

  21. 21
    J. Alfred Witjes, Bladder cancer: Elderly and female patients fare the worst and deserve better, Nature Reviews Urology, 2013, 10, 7, 371

    CrossRef

  22. 22
    Donna E. Hansel, Jeremy S. Miller, Michael S. Cookson, Sam S. Chang, Challenges in the Pathology of Non–Muscle-invasive Bladder Cancer: A Dialogue Between the Urologic Surgeon and the Pathologist, Urology, 2013, 81, 6, 1123

    CrossRef

  23. 23
    J. Alfred Witjes, Joan Palou, Mark Soloway, Donald Lamm, Ashish M. Kamat, Maurizio Brausi, Raj Persad, Roger Buckley, Marc Colombel, Andreas Böhle, Current clinical practice gaps in the treatment of intermediate- and high-risk non-muscle-invasive bladder cancer (NMIBC) with emphasis on the use of bacillus Calmette-Guérin (BCG): results of an international individual patient data survey (IPDS), BJU International, 2013, 112, 6
  24. 24
    Christopher B. Anderson, Daniel A. Barocas, Delivering high-quality care to prostate cancer survivors, Cancer, 2013, 119, 19
  25. 25
    Sten Holmäng, Editorial Comment, Scandinavian Journal of Urology, 2013, 47, 3, 196

    CrossRef

  26. 26
    John L Gore, Scott M Gilbert, Improving bladder cancer patient care: a pharmacoeconomic perspective, Expert Review of Anticancer Therapy, 2013, 13, 6, 661

    CrossRef

  27. 27
    Rianne J.M. Lammers, Richard J. Sylvester, Cheryl T. Lee, J. Alfred Witjes, NMIBC Risk Calculators, Urologic Clinics of North America, 2013, 40, 2, 155

    CrossRef

  28. 28
    Michael C. Large, Joshua A. Cohn, Gary D. Steinberg, Optimal Risk-Adapted Surveillance Strategies for NMIBC, Including Upper Tract Imaging, Urologic Clinics of North America, 2013, 40, 2, 305

    CrossRef

  29. 29
    David C. Johnson, Raj S. Pruthi, Michael E. Woods, Perioperative Chemotherapy, Urologic Clinics of North America, 2013, 40, 2, 183

    CrossRef

  30. 30
    Daniel A. Barocas, Alice Liu, Frank N. Burks, Ronald S. Suh, Timothy G. Schuster, Timothy Bradford, Don A. Moylan, Peter M. Knapp, Daniel S. Murtagh, David Morris, Rodney L. Dunn, James E. Montie, David C. Miller, Practice Based Collaboration to Improve the Use of Immediate Intravesical Therapy after Resection of Nonmuscle Invasive Bladder Cancer, The Journal of Urology, 2013, 190, 6, 2011

    CrossRef

  31. 31
    Karim Chamie, Mark S. Litwin, Jeffrey C. Bassett, Timothy J. Daskivich, Julie Lai, Jan M. Hanley, Badrinath R. Konety, Christopher S. Saigal, Recurrence of high-risk bladder cancer: A population-based analysis, Cancer, 2013, 119, 17
  32. 32
    Andrew C. James, John L. Gore, The Costs of Non-Muscle Invasive Bladder Cancer, Urologic Clinics of North America, 2013, 40, 2, 261

    CrossRef

  33. 33
    Alan L. Kaplan, Mark S. Litwin, Karim Chamie, The future of bladder cancer care in the USA, Nature Reviews Urology, 2013, 11, 1, 59

    CrossRef

  34. 34
    Dorothy L. Rosenthal, Christopher J. VandenBussche, Frances H. Burroughs, Srividya Sathiyamoorthy, Hui Guan, Christopher Owens, The Johns Hopkins Hospital template for urologic cytology samples , Cancer Cytopathology, 2013, 121, 1
  35. 35
    Christopher P. Filson, John T. Wei, John M. Hollingsworth, Trends in Medical Management of Men With Lower Urinary Tract Symptoms Suggestive of Benign Prostatic Hyperplasia, Urology, 2013, 82, 6, 1386

    CrossRef

  36. 36
    Sam S. Chang, Colin P.N. Dinney, S. Machele Donat, Philipp Dahm, John L. Gore, Yair Lotan, Dipen J. Parekh, David B. Solit, Peter H. O'Donnell, Felix Y. Feng, Donna Hansel, Matthew I. Milowsky, 12th Annual Meeting of the Society of Urologic Oncology (SUO) Bladder Cancer Sessions I and II summary report, Urologic Oncology: Seminars and Original Investigations, 2012, 30, 6, 944

    CrossRef

  37. 37
    Maria Frantzi, Manousos Makridakis, Antonia Vlahou, Biomarkers for bladder cancer aggressiveness, Current Opinion in Urology, 2012, 22, 5, 390

    CrossRef

  38. 38
    Lionel Perrier, Alessandra Buja, Giuseppe Mastrangelo, Antonella Vecchiato, Paolo Sandonà, Françoise Ducimetière, Jean-Yves Blay, François Gilly, Carole Siani, Pierre Biron, Dominique Ranchère-Vince, Anne-Valérie Decouvelaere, Philippe Thiesse, Christophe Bergeron, Angelo Dei Tos, Jean-Michel Coindre, Carlo Rossi, Isabelle Ray-Coquard, Clinicians' adherence versus non adherence to practice guidelines in the management of patients with sarcoma: a cost-effectiveness assessment in two European regions, BMC Health Services Research, 2012, 12, 1, 82

    CrossRef

  39. 39
    Willem Oosterlinck, Karel Decaestecker, Current strategies in the treatment of non-muscle-invasive bladder cancer, Expert Review of Anticancer Therapy, 2012, 12, 8, 1097

    CrossRef

  40. 40
    J. Stephen Jones, Editorial Comment, The Journal of Urology, 2012, 187, 5, 1575

    CrossRef

  41. 41
    Sima P. Porten, Matthew R. Cooperberg, High-risk nonmuscle invasive bladder cancer, Current Opinion in Urology, 2012, 22, 5, 385

    CrossRef

  42. 42
    M. Rouprêt, Y. Neuzillet, S. Larré, G. Pignot, P. Coloby, X. Rébillard, P. Mongiat-Artus, E. Chartier-Kastler, M. Soulié, C. Pfister, Recommandations du comité de cancérologie de l’Association française d’urologie (CC-AFU) pour la bonne pratique des instillations endovésicales de BCG et de mytomycine C dans le traitement des tumeurs de la vessie n’envahissant pas le muscle (TVNIM), Progrès en Urologie, 2012, 22, 15, 920

    CrossRef

  43. 43
    Daniel A. Barocas, Denise R. Globe, Danielle C. Colayco, Ahunna Onyenwenyi, Amanda S. Bruno, Thomas J. Bramley, Rachel J. Spear, Surveillance and Treatment of Non-Muscle-Invasive Bladder Cancer in the USA, Advances in Urology, 2012, 2012, 1

    CrossRef

  44. 44
    Frank N. Burks, Alice B. Liu, Ronald S. Suh, Timothy G. Schuster, Timothy Bradford, Don A. Moylan, Peter M. Knapp, Daniel S. Murtagh, Rodney L. Dunn, James E. Montie, David C. Miller, Understanding the Use of Immediate Intravesical Chemotherapy for Patients with Bladder Cancer, The Journal of Urology, 2012, 188, 6, 2108

    CrossRef